SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus
J Eur Acad Dermatol Venereol
.
2023 Sep;37(9):e1094-e1096.
doi: 10.1111/jdv.19144.
Epub 2023 May 6.
Authors
A Dangien
1
,
D Darbord
1
,
J Chanal
1
2
,
J Wendling
1
,
C Pantoja
1
,
B Oules
1
2
3
,
C Lheure
1
,
E Ouedraogo
1
,
N Kramkimel
1
,
M Barret
4
,
F Beuvon
5
,
F Plantier
5
,
S Guegan
1
2
3
,
S Aractingi
1
2
3
,
V Seta
1
,
P Sohier
2
3
5
,
C Isnard
1
,
N Dupin
1
2
3
Affiliations
1
Dermatology Department, Hôpital Cochin, AP-HP, Paris, France.
2
Institut Cochin, INSERM U1016, UMR 8104, Paris, France.
3
Faculté de Médecine Paris Centre Santé, Université Paris Cité, Paris, France.
4
Gastroenterology Department, Hôpital Cochin, AP-HP, Paris, France.
5
Pathology Department, Hôpital Cochin, AP-HP, Paris, France.
PMID:
37114298
DOI:
10.1111/jdv.19144
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Lichen Planus* / chemically induced
Lichen Planus, Oral* / chemically induced
SARS-CoV-2
Vaccination / adverse effects
Substances
COVID-19 Vaccines